腹腔巨大肿物——粘液性肿瘤一例
A Case of a Huge Abdominal Mass-Mucinous Tumor
DOI: 10.12677/acm.2024.14112883, PDF,    科研立项经费支持
作者: 郑小苍, 云 昱, 林 伟*:成都中医药大学临床医学院,四川 成都;成都中医药大学附属医院(四川省中医院)普外科,四川 成都;穆泓吉:成都中医药大学临床医学院,四川 成都
关键词: 腹腔巨大肿物粘液性肿瘤消化道来源手术切除Giant Abdominal Mass Mucinous Tumor Gastrointestinal Origin Surgical Resection
摘要: 粘液性肿瘤多起源于卵巢上皮性肿瘤,生长迅速,因囊肿内较多分泌粘液的上皮,上皮细胞胞浆内含有粘液,此类上皮细胞在宫颈内膜及胃、小肠等消化器官内多见,现报道1例腹腔巨大肿物——粘液性肿瘤(消化系统来源)手术切除,术后病检符合低级别粘液性肿瘤,其来源为消化系统。术后进行三次热灌注化疗,恢复良好,随访复查。通过临床案例报道以探讨粘液性肿瘤的疾病特点及临床诊疗及相关文献复习来提高对此病的认识。
Abstract: Mucinous tumors are mostly originated from ovarian epithelial tumors, growing rapidly, because of more mucus-secreting epithelium in the cysts, and mucus is contained in the epithelial cell envelope, which is common in the endocervical lining and digestive organs such as the stomach and the small intestine, etc. Clinical reports of appendiceal-originated and ovary-originated mucinous tumors are more frequent, and a small number of clinical cases have been reported in the pancreatic ducts papillary mucinous tumors as well as bile ducts. Papillary mucinous tumor in the pancreatic duct and bile duct have been reported in a few clinical cases. We report a case of a large abdominal mass—mucinous tumor (of digestive origin) that was surgically resected, and the postoperative pathology was consistent with a low-grade mucinous tumor, which was of digestive origin. Three times of heat infusion chemotherapy was performed postoperatively with good recovery and follow-up review. A special clinical case report is presented to discuss the disease characteristics and clinical diagnosis and treatment of mucinous tumors and to review the relevant literature to improve the understanding of this disease.
文章引用:郑小苍, 云昱, 穆泓吉, 林伟. 腹腔巨大肿物——粘液性肿瘤一例[J]. 临床医学进展, 2024, 14(11): 330-335. https://doi.org/10.12677/acm.2024.14112883

参考文献

[1] Rouzbahman, M. and Chetty, R. (2013) Mucinous Tumours of Appendix and Ovary: An Overview and Evaluation of Current Practice. Journal of Clinical Pathology, 67, 193-197. [Google Scholar] [CrossRef] [PubMed]
[2] Li, X., Zhou, J., Dong, M. and Yang, L. (2018) Management and Prognosis of Low-Grade Appendiceal Mucinous Neoplasms: A Clinicopathologic Analysis of 50 Cases. European Journal of Surgical Oncology, 44, 1640-1645. [Google Scholar] [CrossRef] [PubMed]
[3] Umetsu, S.E. and Kakar, S. (2023) Staging of Appendiceal Mucinous Neoplasms: Challenges and Recent Updates. Human Pathology, 132, 65-76. [Google Scholar] [CrossRef] [PubMed]
[4] Lu, Z. and Chen, J. (2014) [Introduction of WHO Classification of Tumours of Female Reproductive Organs, Fourth Edition]. Chinese Journal of Pathology, 43, 649-650.
[5] Shih, I. and Kurman, R.J. (2004) Ovarian Tumorigenesis: A Proposed Model Based on Morphological and Molecular Genetic Analysis. The American Journal of Pathology, 164, 1511-1518. [Google Scholar] [CrossRef] [PubMed]
[6] 解建军. 阑尾低级别黏液性肿瘤卵巢转移形态及免疫组织化学诊断研究[M]. 青岛: 卫生医药科技, 2022.
[7] Lertkhachonsuk, A., Buranawongtrakoon, S., Lekskul, N., Rermluk, N., Wee‐Stekly, W. and Charakorn, C. (2020) Serum CA19‐9, CA‐125 and CEA as Tumor Markers for Mucinous Ovarian Tumors. Journal of Obstetrics and Gynaecology Research, 46, 2287-2291. [Google Scholar] [CrossRef] [PubMed]
[8] 林怡婷.不同手术方式治疗卵巢良性及交界性粘液性肿瘤的临床疗效及预后分析[D]: [硕士学位论文]. 福州: 福建医科大学, 2021.
[9] Solomon, D., Bekhor, E., Leigh, N., Maniar, Y.M., Totin, L., Hofstedt, M., et al. (2019) Surveillance of Low-Grade Appendiceal Mucinous Neoplasms with Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience. Annals of Surgical Oncology, 27, 147-153. [Google Scholar] [CrossRef] [PubMed]
[10] 张琪, 汤东, 周家杰, 等. 低级别阑尾黏液性肿瘤58例临床分析[J]. 中国实用外科杂志, 2024, 44(5): 583-587, 593.
[11] Ricci, F., Affatato, R., Carrassa, L. and Damia, G. (2018) Recent Insights into Mucinous Ovarian Carcinoma. International Journal of Molecular Sciences, 19, Article 1569. [Google Scholar] [CrossRef] [PubMed]
[12] Saga, Y. (2012) Cetuximab Inhibits the Growth of Mucinous Ovarian Carcinoma Tumor Cells Lacking KRAS Gene Mutations. Oncology Reports, 27, 1336-1340. [Google Scholar] [CrossRef] [PubMed]
[13] McAlpine, J.N., Wiegand, K.C., Vang, R., Ronnett, B.M., Adamiak, A., Köbel, M., et al. (2009) HER2 Overexpression and Amplification Is Present in a Subset of Ovarian Mucinous Carcinomas and Can Be Targeted with Trastuzumab Therapy. BMC Cancer, 9, Article No. 433. [Google Scholar] [CrossRef] [PubMed]
[14] Bhatt, A. and Glehen, O. (2016) The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review. Indian Journal of Surgical Oncology, 7, 188-197. [Google Scholar] [CrossRef] [PubMed]